# US 2011/0300222 A1 · Luminescent porous silicon nanoparticles, methods of making and using same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0300222 A1
- Document ID: US20110300222A1
- Status: Published application
- Kind: A1
- Application number: 13/202,271
- Filed: 2010-02-20
- Published: 2011-12-08
- Earliest claimed: 2009-02-20
- Assignees: The Regents of the University of California
- Inventors: Michael J. Sailor; Luo Gu; Ji-Ho Park
- Web page: https://patentgrep.com/patent/US20110300222A1

## CPC

- C09K 11/59: containing silicon
- A61K 49/0017: {Fluorescence in vivo}
- A61K 49/0067: {quantum dots, fluorescent nanocrystals}
- A61K 49/0093: {Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle}
- C09K 11/02: Use of particular materials as binders, particle coatings or suspension media therefor
- C09K 11/025: {non-luminescent particle coatings or suspension media}
- Y10T 428/2982: Particulate matter [e.g., sphere, flake, etc.]
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The disclosure relates to imaging agents and drug delivery systems.

## Claims

### Claim 1

A biodegradable porous nanostructure comprising silicon material, an emission spectra of about 500 to about 1000 nm and an excitation spectra between about 290-700 nm by single photon excitation or about 600-1200 nm by two photon excitation.

### Claim 2 (depends on 2)

The biodegradable porous nanostructure of claim 2, wherein the silicon material comprises a silicon dioxide material.

### Claim 3 (depends on 1)

The biodegradable porous nanostructure of claim 1, comprising a particulate size of between about 5 nm and 100 μm.

### Claim 4 (depends on 1)

The biodegradable porous nanostructure of claim 1, wherein the biodegradable porous nanostructure is non-toxic.

### Claim 5 (depends on 1)

The biodegradable porous nanostructure of claim 1, coated or encapsulated within a polymeric material.

### Claim 6 (depends on 5)

The biodegradable porous nanostructure of claim 5, wherein the polymeric material is dextran, polyethylene glycol (PEG), lipids, chitosan, zein, polylactic acid, polyglycolic acid, collagen, fibrin, co-polymers of polylactic acid and polyglycolic acid, and co-polymers of dextran and polylactic acid.

### Claim 7 (depends on 5)

The biodegradable porous nanostructure of claim 5, wherein the polymeric material is dextran.

### Claim 8 (depends on 1)

The biodegradable porous nanostructure of claim 1, further comprising a therapeutic drug.

### Claim 9 (depends on 1)

A method of making a biodegradable porous nanostructure of claim 1, comprising:
electrochemically etching a p-type silicon wafer;
obtaining a free-standing hydrogen-terminated porous silicon film by removing the porous silicon nanostructure from the crystalline silicon substrates;
fracturing the free-standing hydrogen-terminated porous silicon film to obtain a mixture of nanoporous materials of differing sizes;
filtering or size selecting the fractured porous material to obtain a desired size fractionated nanoporous material; and
activating the size fractionated nanoporous material by incubating the material in an aqueous buffer that is oxidizing or neutral to basic to obtain a luminescent porous silicon nanoparticle (LPSiNP).

### Claim 10 (depends on 9)

The method of claim 9, wherein the electrochemical etching is by application of a constant current density of about 200 mA/cm2 for about 150 s in an aqueous HF/ethanol electrolyte.

### Claim 11 (depends on 9)

The method of claim 9, wherein the freestanding film is obtained by application of a current pulse of about 4 mA/cm2 for 250 s in an aqueous HF/ethanol electrolyte.

### Claim 12 (depends on 9)

The method of claim 9, wherein the freestanding hydrogen-terminated porous silicon film is fractured by sonication.

### Claim 13 (depends on 9)

The method of claim 9, wherein the filtering or size selection comprises passing the nanoporous material through a 0.22-0.45 μm filtration membrane, using chromatography or centrifugation.

### Claim 14 (depends on 9)

The method of claim 9, wherein the activating comprises incubating the size fractionated nanoporous material in an aqueous borate buffer.

### Claim 15 (depends on 9)

The method of claim 9, wherein the activating comprises incubating the size fractionated nanoporous material in deionized water for approximately 2 weeks.

### Claim 16 (depends on 9)

The method of claim 9, further comprising physically absorbing dextran to the LPSiNP.

### Claim 17 (depends on 9)

The method of claim 9, further comprising loading a therapeutic drug into the pores of the LPSiNP.

### Claim 18 (depends on 1)

A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a biodegradable porous nanostructure of claim 1.

### Claim 19

A composition comprising:
a biodegradable porous nanostructure comprising silicon, a plurality of pores and comprising an emission spectra of about 500 to about 1000 nm and an excitation spectra between about 290-700 nm by single photon excitation or about 600-1200 nm by two photon excitation; and
a drug or biologically active material within the pores.

### Claim 20 (depends on 19)

The composition of claim 19, further comprising a polymeric coating the increases the half-life or circulatory time of the biodegradable porous nanostructure in vivo.

### Claim 21

A method of preparing a biodegradable imaging agent comprising:
electrochemically etching a p-type silicon wafer;
lifting off a porous film from the silicon wafer substrate;
fractionating the porous film to generate nanostructures;
activating the nanostructure in an oxidizing aqueous buffer.

### Claim 22 (depends on 21)

The method of claim 21, wherein the aqueous buffer comprises a borate solution.

### Claim 23 (depends on 21)

The method of claim 21, wherein the imaging agent comprises an emission spectra of about 500 to about 1000 nm and an excitation spectra between about 290-700 nm by single photon excitation or about 600-1200 nm by two photon excitation.

### Claim 24 (depends on 21)

The method of claim 21, further comprising loading a drug or agent into the pores of the nanostructure.

### Claim 25 (depends on 21)

The method of claim 21, further comprising adsorbing a biocompatible agent to the nanostructure to increase the half-life or circulatory time in vivo.

### Claim 26 (depends on 21)

A nanostructure made by the method of claim 21.

### Claim 27 (depends on 22)

A nanostructure made by the method of claim 22.

### Claim 28 (depends on 23)

A nanostructure made by the method of claim 23.

### Claim 29 (depends on 1)

A method of imaging a tissue, cell, or tumor comprising administering to a tissue, cell, or subject a nanostructure of claim 1, and contacting the tissue, cell or subject with an excitation energy and measuring an emission spectra.
